LONDON (Alliance News) - Niche pharmaceuticals company Quantum Pharma PLC on Tuesday said trading in the first half of 2016 has been in line with its expectations and said its chief executive will step down.
Quantum said its Specials unit has continued to perform well in the first half and it has seen encouraging progress in its Niche Pharmaceuticals unit, increasing confidence in its business model.
“As previously indicated, our performance for the current financial year will be second half weighted as we bring our product pipeline to the market.
